DrugBiological
Immunoglobulins clinical trials
- studies test it
- 43
- open now
- 5
- in phase 3
- 24
- first study started
- 1991
Keep track of what changes. Save the Immunoglobulins studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
42 studies that test it; most in 2020 (6)
| Year | Studies |
|---|---|
| 1991 | 1 |
| 1992 | 1 |
| 1993 | 1 |
| 1995 | 3 |
| 1996 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 2004 | 3 |
| 2005 | 3 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 2
- Phase 2
- 8
- Phase 3
- 24
- Phase 4
- 4
- No phase
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 30
CSL Behring (7) · Assistance Publique - Hôpitaux de Paris (3) · University of Aarhus (3) · University Health Network, Toronto (2) · Baxalta now part of Shire (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · National Center for Research Resources (NCRR) (2) · Takeda (1)
Often tested with
Tested in the same studies.
Immunoglobulins, Intravenous (4) · Aspirin (2) · Solutions (1) · Immunoglobulin G (1) · Hyaluronoglucosaminidase (1) · Albumins (1) · Adrenal Cortex Hormones (1) · Hydroxychloroquine (1)
Studies
Open first, then newest update. How each study uses Immunoglobulins is read from its arms, and is right about nine times in ten.
Testing it · 43
- A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingPhase 3Kedrion S.p.A.NCT06752356Written as Immune globulin (human) 10% solution for intravenous administration
- Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell LymphomaNot yet recruitingPhase 3Assistance Publique - Hôpitaux de ParisNCT07754682Written as Immunoglobulin
- Randomised Evaluation of COVID-19 TherapyRecruitingPhase 3University of OxfordNCT04381936Written as Immunoglobulin
- Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)RecruitingPhase 4University of AarhusNCT04589299Written as Immunoglobulin
- Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell ImpairmentRecruitingPhase 2Jaehoon KoNCT06159283Written as Immunoglobulins
- An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)CompletedPhase 4CSL BehringNCT07076446Written as IgPro
- Subcutaneous Immunoglobulin for Myasthenia GravisCompletedPhase 2University Health Network, TorontoNCT04728425Written as subcutaneous immunoglobulin (SCIG)
- An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency DiseaseCompletedPhase 3TakedaNCT04842643Written as IGSC 20% infusion
- A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)CompletedPhase 3Baxalta now part of ShireNCT04346108Written as Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%)
- A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedPhase 3Baxalta now part of ShireNCT02549170Written as IGIV GAMMAGARD LIQUID/KIOVIG
- Convalescent Antibodies Infusion in Critically Ill COVID 19 PatientsTerminatedNot applicableA.O. Ospedale Papa Giovanni XXIIINCT04346589Written as Anti-coronavirus antibodies (immunoglobulins)obtained with DFPP from convalescent patients
- Convalescent Antibodies Infusion in COVID 19 PatientsWithdrawnNot applicablePiero Luigi RuggenentiNCT04418531Written as Anti-coronavirus antibodies (immunoglobulins) obtained with DFPP form convalescent patients
- Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic SyndromeSuspendedPhase 2/3Assistance Publique - Hôpitaux de ParisNCT03560011Written as immunoglobulin IV
- Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous IgCompletedPhase 2/3Rochester General HospitalNCT03211065Written as 20% subcutaneous immunoglobulin
- Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral ImmunodeficiencyWithdrawnPhase 3Green Cross CorporationNCT03492710Written as Immunoglobulin
- Intravenous Immune Globulin to Treat Hereditary Inclusion Body MyopathyCompletedPhase 1National Human Genome Research Institute (NHGRI)NCT00195637Written as Immune Globulin
- A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's DiseaseCompletedPhase 2/3Instituto Grifols, S.A.NCT01561053Written as Immunoglobulin
- Subcutaneous Ig in Allogeneic Stem Cell Transplant RecipientsCompletedNot applicableUniversity Health Network, TorontoNCT03401268Written as subcutaneous immunoglobulin
- Subcutaneous Ig Maintenance Therapy for Myasthenia GravisTerminatedPhase 1St. Louis UniversityNCT01828294Written as Subcutaneous immunoglobulins
- Human IgGs and Endothelial Function in Vivo in HumansCompletedNot applicableFederico II UniversityNCT03534479Written as Polyclonal IgG
See all 43 studies that test Immunoglobulins →
Given in every arm · 2 — Immunoglobulins is usual care beside what is tested
- Early Immunotherapy with Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients with Anti-Hu-associated Paraneoplastic Sensory NeuronopathyRecruitingPhase 2Assistance Publique - Hôpitaux de ParisNCT06373211Written as Immunoglobulins IV (CLAYRIG)
- A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study)Status unknownPhase 3National Taiwan University HospitalNCT03200561Written as immunoglobulin
As the comparator · 3 — what is tested is compared with Immunoglobulins
- Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingPhase 2University of UlmNCT04881682Written as Immunoglobulins
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or ExtensionRecruitingPhase 2/3Monash UniversityNCT05678621Written as Immunoglobulins
- Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal TransplantationTerminatedPhase 2Brigham and Women's HospitalNCT01895127Written as Immunoglobulin
Codes
What other systems call Immunoglobulins · ClinicalTrials.gg INT007650
- MeSH (NLM) D007136ImmunoglobulinsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007136 | Immunoglobulins | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.